Neutralization of viruses with European, South African, and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine …
The increasing prevalence of SARS-CoV-2 variants with mutations in the spike protein has
raised concerns that recovered individuals may not be protected from reinfection and that …
raised concerns that recovered individuals may not be protected from reinfection and that …
Neutralization of viruses with European, South African, and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine …
T Tada, BM Dcosta, M Samanovic-Golden, RS Herati… - bioRxiv - ncbi.nlm.nih.gov
The increasing prevalence of SARS-CoV-2 variants with mutations in the spike protein has
raised concerns that recovered individuals may not be protected from reinfection and that …
raised concerns that recovered individuals may not be protected from reinfection and that …
Neutralization of viruses with European, South African, and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine …
T Tada, BM Dcosta, M Samanovic-Golden… - Biorxiv: the Preprint …, 2021 - europepmc.org
The increasing prevalence of SARS-CoV-2 variants with mutations in the spike protein has
raised concerns that recovered individuals may not be protected from reinfection and that …
raised concerns that recovered individuals may not be protected from reinfection and that …
Neutralization of viruses with European, South African, and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine …
T Tada, BM Dcosta, M Samanovic-Golden, RS Herati… - bioRxiv, 2021 - biorxiv.org
The increasing prevalence of SARS-CoV-2 variants with mutations in the spike protein has
raised concerns that recovered individuals may not be protected from reinfection and that …
raised concerns that recovered individuals may not be protected from reinfection and that …
Neutralization of viruses with European, South African, and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine …
T Tada, BM Dcosta… - … : the preprint server …, 2021 - pubmed.ncbi.nlm.nih.gov
The increasing prevalence of SARS-CoV-2 variants with mutations in the spike protein has
raised concerns that recovered individuals may not be protected from reinfection and that …
raised concerns that recovered individuals may not be protected from reinfection and that …
[PDF][PDF] Neutralization of viruses with European, South African, and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA …
T Tada, BM Dcosta, M Samanovic-Golden, RS Herati… - researchgate.net
The increasing prevalence of SARS-CoV-2 variants with mutations in the spike protein has
raised concerns that recovered individuals may not be protected from reinfection and that …
raised concerns that recovered individuals may not be protected from reinfection and that …
Neutralization of viruses with European, South African, and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine …
T Tada, BM Dcosta, M Samanovic-Golden, RS Herati… - 2021 - pesquisa.bvsalud.org
The increasing prevalence of SARS-CoV-2 variants with mutations in the spike protein has
raised concerns that recovered individuals may not be protected from reinfection and that …
raised concerns that recovered individuals may not be protected from reinfection and that …
Neutralization of viruses with European, South African, and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine …
T Tada, BM Dcosta, M Samanovic-Golden, RS Herati… - 2021 - pesquisa.bvsalud.org
Neutralization of viruses with European, South African, and United States SARS-CoV-2
variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine-elicited …
variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine-elicited …
Neutralization of viruses with European, South African, and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine …
T Tada, BM Dcosta, M Samanovic-Golden, RS Herati… - 2021 - europepmc.org
The increasing prevalence of SARS-CoV-2 variants with mutations in the spike protein has
raised concerns that recovered individuals may not be protected from reinfection and that …
raised concerns that recovered individuals may not be protected from reinfection and that …